Back to Isotope Catalog
R-11030

Lamotrigine (13C,d3)

Stable isotope standard for analytical research and method development.

Module Type
Stable Isotope Standards
Category
Drugs & TDM
CAS
1246815-13-3
Unlabeled CAS
84057-84-1
PubChem CID
71434238
Molecular Formula
C6[13C]3H4D3Cl2N5
Molecular Weight
262.09
AI Isotope Property & Application AnalysisShow

Isotope Summary

Labels
D3, 13C3
Labeled atoms
6
Isotope positions
Partially confirmed in structure
Calculation reliability
Medium, some information should be confirmed

Mass & MS Parameters

Unlabeled exact mass
255.007851 Da
Labeled exact mass
261.036745 Da
Exact mass shift
6.028895 Da
Nominal mass shift
6
Ionm/zStatus
[M+H]+262.044022Theoretical
[M+Na]+284.025963Theoretical
[M+NH4]+279.070568Theoretical
[M-H]-260.029469Theoretical

Label Stability

Overall
Low risk
Calculation reliability
Medium, some information should be confirmed
  • Carbon-bound deuterium is evaluated by local chemical environment; isotope effects should still be checked experimentally.

Internal Standard Suitability

Rating
High
Chromatographic similarity
Possible isotope effect
Natural isotope overlap
Low
  • Exact mass separation is 6.028895 Da; MS channel separation should be verified in the final method.
  • The unlabeled parent mass was derived from the isotope structure because a curated parent structure was not matched.
  • Overall suitability: High.

Recommended Applications

LC-MS/MS Quantitative Internal Standard
Recommended

LC-MS/MS Quantitative Internal Standard is classified as Recommended based on isotope mapping, mass separation, and label-stability rules.

Isotope Dilution Mass Spectrometry
Recommended

Isotope Dilution Mass Spectrometry is classified as Recommended based on isotope mapping, mass separation, and label-stability rules.

GC-MS Internal Standard
Possible

GC-MS Internal Standard is classified as Possible based on isotope mapping, mass separation, and label-stability rules.

Metabolic Tracing
Not primary

Metabolic Tracing is classified as Not primary based on isotope mapping, mass separation, and label-stability rules.

Clinical Mass Spectrometry
Possible

Clinical Mass Spectrometry is classified as Possible based on isotope mapping, mass separation, and label-stability rules.

AI Interpretation

This analysis is based on isotope-aware structure data. The compound contains D3, 13C3, with an exact mass shift of 6.028895 Da. Label stability is assessed as Low risk, and internal-standard suitability is High. These results support analytical method development and require experimental validation.

AI-assisted analytical guidance is intended for method-development support. Actual isotope stability, chromatographic behavior, fragmentation and MRM transitions should be experimentally validated.